224 related articles for article (PubMed ID: 17665213)
1. Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.
Li PC; Chen LD; Zheng F; Li Y
J Cancer Res Clin Oncol; 2008 Jan; 134(1):37-44. PubMed ID: 17665213
[TBL] [Abstract][Full Text] [Related]
2. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model.
Hribaschek A; Kuhn R; Pross M; Meyer F; Fahlke J; Ridwelski K; Boltze C; Lippert H
Surg Today; 2006; 36(1):57-62. PubMed ID: 16378195
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model.
Yu J; Lee HJ; Hur K; Kwak MK; Han TS; Kim WH; Song SC; Yanagihara K; Yang HK
Invest New Drugs; 2012 Feb; 30(1):1-7. PubMed ID: 20669041
[TBL] [Abstract][Full Text] [Related]
5. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
Colombo PE; Boustta M; Poujol S; Jarlier M; Bressolle F; Teulon I; Ladjemi MZ; Pinguet F; Rouanet P; Vert M
Gynecol Oncol; 2011 Sep; 122(3):632-40. PubMed ID: 21665252
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis].
Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1602-4. PubMed ID: 14619474
[TBL] [Abstract][Full Text] [Related]
8. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin.
Gunji S; Obama K; Matsui M; Tabata Y; Sakai Y
Surgery; 2013 Nov; 154(5):991-9. PubMed ID: 24008088
[TBL] [Abstract][Full Text] [Related]
9. [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].
Hribaschek A; Pross M; Ridwelski K; Meyer F; Fenske A; Krüger S; Lippert H
Zentralbl Chir; 2004 Aug; 129(4):328-34. PubMed ID: 15354258
[TBL] [Abstract][Full Text] [Related]
10. [Intraoperative and postoperative intra-peritoneal administration of peptide PIII inhibits peritoneal metastasis of gastric cancer].
Bai FH; Yang L; Ji Q; Zhang YQ; Liu ZX; Wang ZZ; Yan L; Wang JB; Jin HF; Li TT
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3260-3. PubMed ID: 17313805
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model.
Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H
Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698
[TBL] [Abstract][Full Text] [Related]
12. Study on the inhibitory effect of tyroserleutide on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis.
Li PC; Li Y; Tang ZY; Wang L; Lu R; Xue Q
Hepatogastroenterology; 2007; 54(77):1359-63. PubMed ID: 17708254
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis.
Xu S; Fan H; Yin L; Zhang J; Dong A; Deng L; Tang H
Eur J Pharm Biopharm; 2016 Jul; 104():251-9. PubMed ID: 27185379
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M
Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of peritoneal carcinomatosis in experimental investigations with CPT-11 and oxaliplatin.
Hribaschek A; Pross M; Kuhn R; Krüger S; Ridwelski K; Halangk W; Boltze C; Lippert H
Anticancer Drugs; 2002 Jul; 13(6):605-14. PubMed ID: 12172506
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.
Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H
Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and antitumor evaluation of the albumin-SN38 conjugate.
Yao Y; Su X; Xie Y; Wang Y; Kang T; Gou L; Yi C; Yang J
Anticancer Drugs; 2013 Mar; 24(3):270-7. PubMed ID: 23233044
[TBL] [Abstract][Full Text] [Related]
18. Targeted intraabdominal chemotherapy for peritoneal carcinomatosis.
Samel S; Löhr M
Cancer Treat Res; 2007; 134():469-82. PubMed ID: 17633075
[TBL] [Abstract][Full Text] [Related]
19. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study on intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis].
Maruyama M; Nagahama T; Ebuchi M; Yuasa Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1855-7. PubMed ID: 11086429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
